Artiva Biotherapeutics Files Prospectus To Offer Up To $400M In Securities
-SEC Filing
Share
Why It Matters
Artiva is asking permission to raise up to $400 million by selling new shares or bonds to investors. When a company does this, it's planning something big—like research or growth—so watch if they tell us what the money is for.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.